Ronald Kamdem
Stock Analyst at Morgan Stanley
(3.88)
# 649
Out of 4,975 analysts
197
Total ratings
56.44%
Success rate
8.02%
Average return
Main Sectors:
Stocks Rated by Ronald Kamdem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VICI VICI Properties | Maintains: Equal-Weight | $33 → $35 | $33.60 | +4.17% | 5 | Jul 8, 2025 | |
| LINE Lineage | Downgrades: Equal-Weight | $75 → $50 | $40.59 | +23.18% | 3 | Jun 23, 2025 | |
| CBRE CBRE Group | Maintains: Overweight | $160 → $170 | $164.38 | +3.42% | 5 | Jun 12, 2025 | |
| SNDA Sonida Senior Living | Maintains: Equal-Weight | $25 → $26 | $25.80 | +0.78% | 2 | May 20, 2025 | |
| AHR American Healthcare REIT | Maintains: Overweight | $37 → $45 | $42.73 | +5.31% | 5 | May 20, 2025 | |
| WELL Welltower | Maintains: Overweight | $155 → $160 | $167.82 | -4.66% | 6 | May 6, 2025 | |
| CURB Curbline Properties | Maintains: Equal-Weight | $27 → $26 | $22.95 | +13.29% | 2 | Apr 24, 2025 | |
| MAC The Macerich Company | Maintains: Equal-Weight | $20 → $19 | $18.75 | +1.33% | 2 | Apr 1, 2025 | |
| PGRE Paramount Group | Maintains: Equal-Weight | $4.25 → $4 | $7.55 | -47.02% | 6 | Mar 18, 2025 | |
| HPP Hudson Pacific Properties | Maintains: Underweight | $2.4 → $2.25 | $3.07 | -26.71% | 10 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $26 → $28 | $41.29 | -32.19% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $53 | $48.43 | +9.44% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $22 | $13.41 | +64.06% | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $293 → $315 | $297.80 | +5.78% | 17 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $133 | $113.65 | +17.03% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $62 | $59.29 | +4.57% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $9.70 | -27.84% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.8 → $1.6 | $0.23 | +608.28% | 15 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $18 → $21 | $31.85 | -34.07% | 10 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $143 → $145 | $182.25 | -20.44% | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $14 → $18 | $21.20 | -15.09% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $62 → $75 | $73.65 | +1.83% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $115 → $150 | $147.28 | +1.85% | 20 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $32 | $33.30 | -3.90% | 20 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $47 | $67.91 | -30.79% | 3 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $24 | $16.85 | +39.47% | 7 | Jul 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $38 → $35 | $61.99 | -43.54% | 5 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $67 | $76.83 | -12.79% | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $18.68 | +1.71% | 6 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $46 | $43.35 | +6.11% | 6 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $77 → $73 | $73.05 | -0.07% | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $195 → $150 | $168.17 | -10.80% | 1 | Oct 17, 2022 |
VICI Properties
Jul 8, 2025
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $33.60
Upside: +4.17%
Lineage
Jun 23, 2025
Downgrades: Equal-Weight
Price Target: $75 → $50
Current: $40.59
Upside: +23.18%
CBRE Group
Jun 12, 2025
Maintains: Overweight
Price Target: $160 → $170
Current: $164.38
Upside: +3.42%
Sonida Senior Living
May 20, 2025
Maintains: Equal-Weight
Price Target: $25 → $26
Current: $25.80
Upside: +0.78%
American Healthcare REIT
May 20, 2025
Maintains: Overweight
Price Target: $37 → $45
Current: $42.73
Upside: +5.31%
Welltower
May 6, 2025
Maintains: Overweight
Price Target: $155 → $160
Current: $167.82
Upside: -4.66%
Curbline Properties
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $27 → $26
Current: $22.95
Upside: +13.29%
The Macerich Company
Apr 1, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $18.75
Upside: +1.33%
Paramount Group
Mar 18, 2025
Maintains: Equal-Weight
Price Target: $4.25 → $4
Current: $7.55
Upside: -47.02%
Hudson Pacific Properties
Mar 18, 2025
Maintains: Underweight
Price Target: $2.4 → $2.25
Current: $3.07
Upside: -26.71%
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $26 → $28
Current: $41.29
Upside: -32.19%
Jan 15, 2025
Downgrades: Equal-Weight
Price Target: $53
Current: $48.43
Upside: +9.44%
Jan 3, 2025
Maintains: Overweight
Price Target: $23 → $22
Current: $13.41
Upside: +64.06%
Oct 2, 2024
Maintains: Equal-Weight
Price Target: $293 → $315
Current: $297.80
Upside: +5.78%
Aug 14, 2024
Maintains: Overweight
Price Target: $132 → $133
Current: $113.65
Upside: +17.03%
Aug 6, 2024
Reinstates: Equal-Weight
Price Target: $62
Current: $59.29
Upside: +4.57%
Apr 10, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $9.70
Upside: -27.84%
Mar 28, 2024
Maintains: Underweight
Price Target: $1.8 → $1.6
Current: $0.23
Upside: +608.28%
Mar 28, 2024
Maintains: Underweight
Price Target: $18 → $21
Current: $31.85
Upside: -34.07%
Feb 26, 2024
Maintains: Equal-Weight
Price Target: $143 → $145
Current: $182.25
Upside: -20.44%
Dec 21, 2023
Upgrades: Equal-Weight
Price Target: $14 → $18
Current: $21.20
Upside: -15.09%
Dec 21, 2023
Upgrades: Overweight
Price Target: $62 → $75
Current: $73.65
Upside: +1.83%
Dec 21, 2023
Upgrades: Equal-Weight
Price Target: $115 → $150
Current: $147.28
Upside: +1.85%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $42 → $32
Current: $33.30
Upside: -3.90%
Sep 7, 2023
Maintains: Equal-Weight
Price Target: $45 → $47
Current: $67.91
Upside: -30.79%
Jul 5, 2023
Maintains: Equal-Weight
Price Target: $30 → $24
Current: $16.85
Upside: +39.47%
Mar 9, 2023
Maintains: Equal-Weight
Price Target: $38 → $35
Current: $61.99
Upside: -43.54%
Mar 9, 2023
Maintains: Equal-Weight
Price Target: $68 → $67
Current: $76.83
Upside: -12.79%
Dec 16, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $18.68
Upside: +1.71%
Nov 2, 2022
Maintains: Equal-Weight
Price Target: $45 → $46
Current: $43.35
Upside: +6.11%
Nov 2, 2022
Maintains: Overweight
Price Target: $77 → $73
Current: $73.05
Upside: -0.07%
Oct 17, 2022
Maintains: Equal-Weight
Price Target: $195 → $150
Current: $168.17
Upside: -10.80%